Contemporary biomarker testing rates in both early and advanced NSCLC: Results from the MYLUNG pragmatic study.

Authors :: Evangelist, Makenzi Colleen
Butrynski, James Edward
Paschold, John C.
Ward, Patrick J.
Spira, Alexander I.
Ali, Kashif
Espirito, Janet L.
Hakimian, David
Jotte, Robert M.
Koselke, Beth
Larson, Timothy
Meshad, Michael W.
Neubauer, Marcus A.
Ogden, Katie
Owera, Rami
Richards, Donald A.
Robert, Nicholas J.
Walberg, Jennifer M.
Wang, Yunfei
Coleman, Robert L.
Source :: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p9109-9109, 1p
Publication Year :: 2023

Full Text Access

Tools